Author

A. Zaza

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Physiology· 2 Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Organism:mouse· 2 Organism:rat· 2 Research Focus:benchmarking· 1 Assay:bulk RNA-seq· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:cell type annotation· 1 Research Focus:clustering· 1

Frequent Co-Authors

C. Ronchi· 2 shared E. Torre· 2 shared M. Ferrandi· 2 shared M. Rocchetti· 2 shared P. Barassi· 2 shared A. Luraghi· 1 shared A. S. Maione· 1 shared C. Florindi· 1 shared

Activity by Year

2021-2023 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 29 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersPhysiology

C. Ronchi

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Early consequences of the phospholamban mutation PLN-R14del+/- in a transgenic mouse model

C. Maniezzi, M. Eskandr, C. Florindi, M. Ferrandi, P. Barassi, E. Sacco, V. Pasquale, A. S. Maione, G. Pompilio, V. Oliveira Nunes Teixeira, R. A. de Boer, H. H. W. Sillje, F. Lodola, A. Zaza

This study examines Ca2+ dynamics and energy metabolism in a transgenic mouse model of the PLN-R14del mutation before cardiomyopathy onset, finding altered mitochondrial function and ER-stress activation.

bioRxiv · Apr 5, 2023Physiology

Batch Action PoTential Analyser (BAPTA): an open source tool for automated high throughput analysis of cardiac action potentials

V. Leonov, E. Torre, C. Ronchi, L. Crotti, P. J. Schwartz, M. Rocchetti, A. Zaza, L. Sala

BAPTA automates cardiac action potential analysis, improving throughput and reproducibility across multiple species and conditions.

bioRxiv · Mar 1, 2023 · PreprintPhysiology

Istaroxime metabolite PST3093 selectively stimulates SERCA2a and reverses disease-induced changes in cardiac function

M. Arici, M. Ferrandi, P. Barassi, S.-C. Hsu, E. Torre, A. Luraghi, C. Ronchi, G.-J. Chang, F. Peri, P. Ferrari, G. Bianchi, M. Rocchetti, A. Zaza

This paper investigates PST3093, a metabolite of istaroxime, showing it selectively stimulates SERCA2a and improves cardiac function in a rat model of diabetic cardiomyopathy.

bioRxiv · Aug 17, 2021Pharmacology & Toxicology